Could a diabetes injection curb cannabis cravings? small trial aims to find out
NCT ID NCT07671248
First seen Jun 27, 2026 · Last updated Jul 01, 2026 · Updated 2 times
Summary
This 12-week study tests whether a weekly injection of tirzepatide, a drug used for diabetes, combined with motivational therapy can help adults with moderate to severe cannabis use disorder. Fifteen participants will receive escalating doses of tirzepatide along with counseling. The main goals are to see if the treatment is safe and tolerable, and whether it reduces cannabis use. This is a very early proof-of-concept trial, so results are not yet known.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Tirzepatide (a diabetes drug that may reduce cravings) combined with motivational therapy
What this could lead to
If it works, this could point toward a new treatment option for cannabis use disorder by reducing cravings and withdrawal.
What could go wrong
This is a very small early proof-of-concept study with only 15 people, so results may not apply broadly. The drug may cause side effects like nausea or vomiting, and it's not yet known if it actually reduces cannabis use.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CANNABIS USE DISORDER, MODERATE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
MacAnxiety Research Centre
Hamilton, Ontario, L8S 1B8, Canada
Contact Phone: •••-•••-•••• Email: •••••@•••••